Selecting the first chemical molecule inhibitor of HSP110 for colorectal cancer therapy.
Gozzi, G.J., Gonzalez, D., Boudesco, C., Dias, A.M.M., Gotthard, G., Uyanik, B., Dondaine, L., Marcion, G., Hermetet, F., Denis, C., Hardy, L., Suzanne, P., Douhard, R., Jego, G., Dubrez, L., Demidov, O.N., Neiers, F., Briand, L., Sopkova-de Oliveira Santos, J., Voisin-Chiret, A.S., Garrido, C.(2020) Cell Death Differ 27: 117-129
- PubMed: 31068676 
- DOI: 10.1038/s41418-019-0343-4
- Primary Citation of Related Structures:  
6GFA - PubMed Abstract: 
Pro-survival stress-inducible chaperone HSP110 is the only HSP for which a mutation has been found in a cancer. Multicenter clinical studies demonstrated a direct association between HSP110 inactivating mutation presence and excellent prognosis in colorectal cancer patients ...